DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

U.S. Army Medical Research and Materiel Command


February 14, 2001

Department of Defense Prostate Cancer Research Program for 2001

The Fiscal Year (FY) 2001 Defense Appropriations Act provides $100M to the Department of Defense Prostate Cancer Research Program (PCRP). This program has been administered since FY97 by the U.S. Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP). The FY01 PCRP is requesting proposals through two separate Program Announcements.

FY01 PCRP Program Announcement I was released December 13, 2001, and invites proposal submissions through three mechanisms:

  • Idea Development Awards


  • New Investigator Awards


  • Postdoctoral Traineeship Awards


  • Proposal receipt deadline for these mechanisms is March 21, 2001.

FY01 PCRP Program Announcement II invites proposals though five new mechanisms:

  • Health Disparity Training-Prostate Scholar Awards


  • Health Disparity Research-Prostate Scholar Awards


  • Historically Black Colleges & Universities (HBCU) Collaborative Partnership Awards


  • Prostate Cancer Clinical Trial Awards


  • Prostate Cancer Consortium Development Awards

Proposal receipt deadline for the Consortium Development Awards is August 29, 2001. Proposal receipt deadline for all other mechanisms in Program Announcement II is June 6, 2001.

Health Disparity Training-Prostate Scholar Awards are intended to support research training that focuses on the disparate burden of prostate cancer in African Americans. They are designed for predoctoral students, postdoctoral trainees, and physicians who recently completed postresidency training. Funding may be requested for up to $90,000 for predoctoral; $147,000 for postdoctoral; and $300,000 for postresidency traineeships (direct and indirect costs) over a 3-year period.

Health Disparity Research-Prostate Scholar Awards are intended to support research that focuses on the disparate burden of prostate cancer in African Americans. They are designed for scientists or physicians at the Assistant Professor level or equivalent who are not yet established researchers. Funding may be requested for up to $300,000 per award (direct costs) over a 3-year period.

HBCU Collaborative Partnership Awards are intended to create partnerships between the applicant HBCU and a collaborating non-HBCU to establish and sustain independent research and training programs at the HBCU that address prostate cancer disparity in the African-American population. Funding may be requested for up to $600,000 (direct costs) over a 3-year period.

Prostate Cancer Clinical Trial Awards are intended to support prospective Phase I or II clinical trials that incorporate a plan to collect correlative data that address mechanisms of clinical efficacy. They are intended for investigators at all levels of experience. Funding may be requested for up to $2M (direct costs) over a 3-year period.

Prostate Cancer Consortium Development Awards are intended to support initial developmental phases required to establish a consortium that will address a major, coordinated, goal/product-driven research effort that is national in scope. Proposals for the full Consortium Award will be requested in FY02 pending receipt of FY02 funds. Funds for the FY01 Consortium Development Award may be requested for up to $150,000 (direct and indirect costs) for a 1-year period.

Detailed descriptions, evaluation criteria, proposal submission requirements, and additional related information for all award mechanisms can be found in the FY01 PCRP Program Announcements. Both documents may be downloaded from the CDMRP Web site at http://cdmrp.army.mil/funding.